SOPH   $3.9  -7.80% Market Closed

Sophia Genetics SA
Total Cash 105.40M
totalCashPerShare 1.592
EBITDA -68.01M
Total Debt 30.07M
quickRatio 4.031
currentRatio 4.396
Total Revenue 64.94M
debtToEquity 24.761
Revenue/Share 0.993
ROA -0.21403
ROE -0.45562
grossProfits
freeCashflow -30.07M
operatingCashflow -47.30M
earningsGrowth
revenueGrowth 0.05
grossMargins 0.68301004
ebitdaMargins -1.04737
operatingMargins -0.9492
profitMargins -1.0284
enterpriseValue 190.17M
forwardPE -4.9135804
floatShares 47.05M
sharesOutstanding 66.21M
sharesShort 39.43K
sharesShortPriorMonth 69.83K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.50%
Short Ratio help_outline 0.45%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 1.834
Price To Book help_outline 2.17
earningsQuarterlyGrowth
netIncomeToCommon -66.78M
trailingEps -1.02%
forwardEps -0.81%
enterpriseToEbitda -2.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 41
lastUpdated Sept. 16, 2024, 8:29 p.m.